Task: Answer the MCQ question.
Question: Which drug exhibits a -27.352% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. CCn1c(=O)c2c(n3c(=S)[nH]nc13)-c1ccccc1CC21CCCCC1
b. CCC1CCCCN1C(=S)NC1CCCCC1
Answer: a. CCn1c(=O)c2c(n3c(=S)[nH]nc13)-c1ccccc1CC21CCCCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCn1c(=O)c2c(n3c(=S)[nH]nc13)-c1ccccc1CC21CCCCC1
CCn1c(=O)c2c(n3c(=S)[nH]nc13)-c1ccccc1CC21CCCCC1
12-ethyl-16-sulfanylidenespiro[12,14,15,17-tetrazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(10),2,4,6,13-pentaene-9,1'-cyclohexane]-11-one